相似文献
1
What is my risk of developing cardiovascular disease?
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S2-7. doi: 10.1097/01.hjr.0000359226.50399.59.
2
The SHAPE paradigm: a commentary.
Circ Cardiovasc Qual Outcomes. 2010 Jan;3(1):106-9. doi: 10.1161/CIRCOUTCOMES.109.908780.
3
Screening for safe sports participation: do for yourself what you tell your patients.
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S14-6. doi: 10.1097/01.hjr.0000359229.35152.d4.
4
Stair use for cardiovascular disease prevention.
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S17-8. doi: 10.1097/01.hjr.0000359230.73270.2e.
5
Heart health or cardiovascular disease?
Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):373-4. doi: 10.1097/HJR.0b013e32833acdc3.
6
Invited commentary.
J Vasc Surg. 2009 Dec;50(6):1376-7. doi: 10.1016/j.jvs.2009.07.099.
7
[HeartScore, PC-based cardiovascular risk assessment. A cooperation between general practitioners and cardiologists].
Lakartidningen. 2005;102(24-25):1893-5.
8
Low-cost strategies to predict cardiovascular disease.
Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):518-9. doi: 10.1038/ncpcardio1294. Epub 2008 Jul 15.
9
More on thromboprophylaxis: quantifying risk for venous thromboembolism.
Thromb Haemost. 2009 Apr;101(4):791-4.
10
Impact of guidelines of the management of cardiovascular risk factors in diabetic patients with macrovascular disease.
Int Angiol. 2010 Feb;29(1):87-8.
引用本文的文献
1
Machine learning methodologies versus cardiovascular risk scores, in predicting disease risk.
BMC Med Res Methodol. 2018 Dec 29;18(1):179. doi: 10.1186/s12874-018-0644-1.
Zotero 插件